Tuesday, November 07, 2006

HR knows you have herpes

for lack of agreement as to what we should post first, the email below will have to suffice.

caroline received it at work the other day.
it seems HR knows she's on methadone. i wonder whether they know it's interacting with any other drugs she's taking. like heroin.



-----Original Message-----
From: Sanford, Angela
Sent: Thursday, November 02, 2006 4:57 PM
To: DWI Employees
Subject: Prescriptions




Dear Employee - today we received the most expensive monthly
prescription invoice in the history of DWI Holdings. The amount is
$25,855.44. What makes this amount even worse is because there are
fewer employees today than ever before. This invoice also contained
billing for the most brand medicines - where generics are available -
than ever before. In 2005, the average per covered employee was
$1514; 2006 is $1692. But if we stay on track with the $25,855
invoices, we're looking at over $2350 per employee. Stop and think
how much this average amount really is - per prescription - since many
covered participants do not take any medications.



Most of you are unaware what the actual cost of your medicine is. Please call me and I will review with you. Please help to lower this expense. Talk to your doctor about generics or, if generics are unavailable, alternate brand medicines. If you're prescribed a new maintenance medicine and unsure if you will be able to tolerate it, ask for samples. If no samples are available, ask for a 1-2 week prescription. And take advantage of Wal-Mart's $4 generics. Attached is a good article that recently appeared in the Wall Street Journal.



Additionally, with today's invoice, I checked interactions for 3 participants. All were found to have mild to moderate problems. When interactions are noted, you must discuss with your doctor(s) to make sure they are aware of ALL of the drugs you are taking (including over-the-counter, vitamins, herbs, etc.).



If you have any questions, comments or suggestions, please contact me. Thank you.

No comments: